A carregar...
New Targeted Treatments for Cutaneous T-cell Lymphomas
Cutaneous T-cell lymphomas (CTCLs) represent a group of rare and heterogeneous diseases that are very difficult to treat at advanced stages. The development of monoclonal antibodies is a new hope for the treatment of these diseases. Alemtuzumab (Campath) is a humanized IgG1 kappa monoclonal antibody...
Na minha lista:
| Publicado no: | Indian J Dermatol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363137/ https://ncbi.nlm.nih.gov/pubmed/28400633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_73_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|